What Do Trump’s E-Health Changes Mean for Medical Research?

Elligo’s scientific innovation officer, Rebecca Kush, PhD, was interviewed by Bloomberg Law based on her experience on clinical data and medical research as a follow up to Seema Verma, administrator of the centers for Medicare & Medicaid services, recent announcement to revamp the meaningful requirements. Read the full interview on Bloomberg Law.